Market Highlights: The global carcinoembryonic antigen market Size is expected to grow 6.7% during the forecast period. Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions....

Market Highlights: Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA...

Market Highlights: The global carcinoembryonic antigen market Size is expected to grow 6.7% during the forecast period. Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions....

Market Highlights: The global carcinoembryonic antigen market Growth is expected to grow 6.7% during the forecast period. Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous...

Market Highlights According to MRFR analysis, Global Remdesivir (COVID 19) Market is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027. Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been...